EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology

Patrícia R S Rodrigues, Aljawharah Alrubayyi, Ellie Pring, Valentina M T Bart, Ruth Jones, Clarissa Coveney, Fangfang Lu, Michael Tellier iD, Shayda Maleki-Toyserkani, Felix C Richter iD, D Oliver Scourfield, Ester Gea-Mallorquí iD und 1 weitere

Oxford Open Immunology · 2020

DOI: 10.1093/oxfimm/iqaa005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxford Open Immunology, 2020. Verfasst von Patrícia R S Rodrigues und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a global health crisis and will likely continue to impact public health for years. As the effectiveness of the innate immune response is crucial to patient outcome, huge efforts have been made to understand how dysregulated immune responses may contribute to disease progression. Here we have reviewed current knowledge of cellular innate immune responses to SARS-CoV-2 infection, highlighting areas for further investigation and suggesting potential strategies for intervention. We conclude that in severe COVID-19 initial innate responses, primarily type I interferon, are suppressed or sabotaged which results in an early interleukin (IL)-6, IL-10 and IL-1β-enhanced hyperinflammation. This inflammatory environment is driven by aberrant function of innate immune cells: monocytes, macrophages and natural killer cells dispersing viral pathogen-associated molecular patterns and damage-associated molecular patterns into tissues. This results in primarily neutrophil-driven pathology including fibrosis that causes acute respiratory distress syndrome. Activated leukocytes and neutrophil extracellular traps also promote immunothrombotic clots that embed into the lungs and kidneys of severe COVID-19 patients, are worsened by immobility in the intensive care unit and are perhaps responsible for the high mortality. Therefore, treatments that target inflammation and coagulation are promising strategies for reducing mortality in COVID-19.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Innate immunologyMacrophagesMonocytesNK cellsNeutrophils

Autor:innen und Institutionen

  • Division of Infection and Immunity, School of Medicine, Systems Immunity Research Institute, Cardiff University, Cardiff, UK.
  • Nuffield Department of Medicine, Viral Immunology Unit, University of Oxford, Oxford, UK.
  • Dementia Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.

ORCID-Profile: Michael Tellier, Felix C Richter, Ester Gea-Mallorquí, Luke C Davies

Zitieren

APA

Rodrigues, P. R. S., Alrubayyi, A., Pring, E., Bart, V. M. T., Jones, R., Coveney, C., Lu, F., Tellier, M., Maleki-Toyserkani, S., Richter, F. C., Scourfield, D. O., Gea-Mallorquí, E., & Davies, L. C. (2020). Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology. Oxford Open Immunology. https://doi.org/10.1093/oxfimm/iqaa005

Vancouver

Rodrigues PRS, Alrubayyi A, Pring E, Bart VMT, Jones R, Coveney C, et al. Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology. Oxford Open Immunology. 2020. doi:10.1093/oxfimm/iqaa005

BibTeX
@article{Rodrigues2020,
  author = {Rodrigues, Patrícia R S and Alrubayyi, Aljawharah and Pring, Ellie and Bart, Valentina M T and Jones, Ruth and Coveney, Clarissa and Lu, Fangfang and Tellier, Michael and Maleki-Toyserkani, Shayda and Richter, Felix C and Scourfield, D Oliver and Gea-Mallorquí, Ester and Davies, Luke C},
  title = {Innate immunology in COVID-19—a living review. Part II: dysregulated inflammation drives immunopathology},
  journal = {Oxford Open Immunology},
  year = {2020},
  doi = {10.1093/oxfimm/iqaa005}
}
Kostenlos starten →